-
Pathfinder Members' Briefing and Q&A - January 2024
17 January 2024
Recording of January's Members' Briefing and Q&A
-
EU’s potential ban on PFAS mothballed?
26 October 2023
The European Commission’s work programme for 2024 is ominously light on the progression of promises to ban highly toxic and persistent PFAS chemicals.
News / Health / Sustainability / Education / Campaigns
-
EU continues to tighten noose on vitamin and mineral limits
12 June 2023
European regulator, EFSA, continues its assault on individual nutrient tolerable upper limits, ANH responds to its latest consultation on vitamin D to protect consumer freedom of choice
-
ANH News Beat (week 40/2023)
04 October 2023
Our weekly roundup of the latest natural and covid news in one place. Read the headlines or click on the links to find out more
-
ANH News Beat (week 33/2023)
16 August 2023
Our weekly roundup of the latest natural and covid news in one place. Read the headlines or click on the links to find out more
-
Health Professonal Masterclass: The great menopause supplement myth
29 August 2023
Join Registered Nutritionist Charlotte Hunter for a fascinating dive into the role of supplements in supporting women through menopause
-
Pathfinder Health Professonal Masterclass: The great menopause supplement myth
29 August 2023
Join Registered Nutritionist Charlotte Hunter for a fascinating dive into the role of supplements in supporting women through menopause
-
Health Professonal Masterclass: The great menopause supplement myth
29 August 2023
Join Registered Nutritionist Charlotte Hunter for a fascinating dive into the role of supplements in supporting women through menopause
-
FEATURE: How the Nobel Prize Summit sold out on real science
12 June 2023
Despite noble ambitions, the Washington DC Nobel summit looked more like a breeding ground for AI-infused dogma and big corporate backed pseudoscience
News / ANH Covid Zone / Health / Campaigns
-
EU prepares for ban on therapeutic doses of B6
15 February 2023
Halving the previous Tolerable Upper Level without any new risk data signals EU intention to limit freedom of choice and prevent the vitamin’s high dose use that includes reducing Alzheimer’s risk and symptoms of premenstrual syndrome